Bulimia Nervosa Epidemiology

• Bulimia Nervosa is a serious psychiatric eating disorder characterized by recurrent episodes of binge eating followed by compensatory behaviors such as self-induced vomiting, excessive exercise, fasting, or misuse of laxatives to prevent weight gain. The disorder is strongly associated with distorted body image, excessive concern about body weight, and emotional distress. 
• The underlying pathology involves a complex interplay of psychological, neurobiological, genetic, and sociocultural factors. Dysregulation of serotonin pathways, impaired impulse control, mood disturbances, and societal pressure related to body image contribute to the development and persistence of the disorder. These factors often coexist with anxiety, depression, and obsessive-compulsive behaviors, increasing disease complexity and chronicity. 
• The condition commonly affects adolescents and young adults, particularly females, and typically presents with recurrent binge-eating episodes, purging behaviors, fluctuations in body weight, fatigue, gastrointestinal disturbances, and psychological symptoms such as guilt, shame, and low self-esteem. In severe cases, electrolyte imbalance, dehydration, cardiovascular complications, and dental erosion may occur, significantly impacting overall health and quality of life. 
• Diagnosis relies on comprehensive clinical and psychiatric evaluation supported by standardized diagnostic criteria such as DSM-5 guidelines. Assessment includes evaluation of eating behaviors, compensatory patterns, psychological symptoms, and physical health status. Laboratory testing and physical examination are often performed to identify nutritional deficiencies, metabolic abnormalities, and complications associated with recurrent purging behaviors. 
• Despite increasing awareness, Bulimia Nervosa continues to represent a substantial clinical and socioeconomic burden due to underdiagnosis, high relapse rates, psychiatric comorbidities, and long-term treatment requirements. Growing mental health awareness, improved access to specialized care, and expanding recognition of eating disorders are contributing to a rising diagnosed patient population globally.

Bulimia Nervosa Epidemiology Forecast in the 7MM

• 2025 Diagnosed Prevalent Cases of Bulimia Nervosa: ~ XXXX million
• 2036 Projected Diagnosed Prevalent Cases of Bulimia Nervosa: XXXX million
• Bulimia Nervosa Growth Rate (2026–2036): XX% CAGR

DelveInsight's ‘Bulimia Nervosa Epidemiology Forecast 2036’ report delivers an in-depth understanding of the bulimia nervosa, historical and forecasted epidemiology of the United States, EU4 (Germany, Spain, Italy, and France), and the United Kingdom, and Japan.

Bulimia Nervosa Disease Understanding

Bulimia Nervosa Overview

Bulimia Nervosa is a serious eating disorder characterized by recurrent binge-eating episodes followed by compensatory behaviors such as self-induced vomiting, fasting, excessive exercise, or misuse of laxatives to prevent weight gain. The condition is strongly associated with body image dissatisfaction, anxiety, depression, and low self-esteem, and commonly affects adolescents and young adults. If untreated, it can lead to severe physical and psychological complications. Diagnosis of Bulimia Nervosa is primarily based on clinical and psychiatric evaluation using DSM-5 criteria. Physicians assess eating behaviors, compensatory patterns, psychological symptoms, and body image concerns through patient interviews and screening tools. Laboratory tests and physical examinations may also be conducted to identify nutritional deficiencies and medical complications.

Further details are provided in the report.

Bulimia Nervosa Epidemiology

Key Findings from Bulimia Nervosa Epidemiological Analysis and Forecast 

• The lifetime prevalence rates for bulimia nervosa ranged from 0.3–4.6% in females and from 0.1–1.3% in males.
• The pooled overall lifetime prevalence rate rose to 1.4% when using only studies that applied DSM-5 criteria (18%; all in Western countries).
• According to a secondary analysis, during the period from 1990 to 2021, the number of individuals affected by bulimia nervosa increased by 67%, rising from 7,416,420 cases to 12,367,024 cases.
• One-year prevalence of bulimia nervosa is 0.32% for females and 0.05% for males.

Scope of the Report

• The report covers a segment of a descriptive overview of bulimia nervosa, explaining its causes, signs and symptoms, and pathogenesis.
• Comprehensive insight has been provided into the epidemiology segments and forecasts, the future growth potential of the diagnosis rate, and disease progression. 

Report Insights

Bulimia Nervosa Patient Population Forecast

Report Key Strengths

• Epidemiology‑based (Epi‑based) bottom‑up forecasting
• 11-year forecast 
• Patient Burden trends (by geography)

Key Questions Answered

• What are the disease risks, burdens, and unmet needs of bulimia nervosa? What will be the growth opportunities across the 7MM concerning the patient population with bulimia nervosa?
• What is the historical and forecasted bulimia nervosa patient pool in the US, EU4 (Germany, France, Italy, and Spain), the UK, and Japan?

Reasons to Buy

• Insights on patient burden/disease prevalence, evolution in diagnosis, and factors contributing to the change in the epidemiology of the disease during the forecast years.
• To understand key opinion leaders’ perspectives on the diagnostic challenges to overcome barriers in the future.
• Detailed insights into various factors hampering disease diagnosis and other existing diagnostic challenges.